# RTOG 1308 (NCT01993810)

> Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: inoperable stage II-IIIB NSCLC

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01993810
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Radiation Therapy Oncology Group
- Conditions: Stage II Non-Small Cell Lung Cancer AJCC v7; Stage IIA Non-Small Cell Lung Carcinoma AJCC v7; Stage IIB Non-Small Cell Lung Carcinoma AJCC v7; Stage III Non-Small Cell Lung Cancer AJCC v7; Stage IIIA Non-Small Cell Lung Cancer AJCC v7; Stage IIIB Non-Small Cell Lung Cancer AJCC v7
- Interventions: Carboplatin; Cisplatin; Durvalumab; Etoposide; Paclitaxel; Pemetrexed Disodium; Photon Beam Radiation Therapy; Proton Beam Radiation Therapy; Quality-of-Life Assessment; Questionnaire Administration
- Enrollment: 330
- Primary outcome: Overall Survival

## Indexed commentary on RTOG 1308 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 26 posts on X
- 2 podcast episodes

## Order

Deep, $1,950 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=rtog-1308-nct01993810

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT01993810", "email": "<work email>"}; the inbox owner confirms by the emailed link.